Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium 2024

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that one oral presentation and 11 posters across its development programs will be included at the 20th Annual WORLDSymposium 2024, being held February 4-9, 2024 in San Diego, CA.

Oral Platform Presentation:

Fabry Disease:

Abstract Title: Trial in progress: An open-label study (AT1001-025) to evaluate the safety and pharmacokinetics of migalastat in patients with Fabry disease and amenable GLA variants and severe renal impairment or end-stage renal disease treated with hemodialysis

• Presenter: Franklin Johnson, MS, Amicus Therapeutics, Inc., Princeton, NJ, U.S.A.
• Date and time: Thursday, February 8, 9:12 – 9:24 a.m. PT

Poster Sessions:

Fabry Disease:

Abstract Title: Multiorgan involvement in females with Fabry disease: Results from two Phase III trials and the followME registry (Poster #246)

• Presenter: Peter Nordbeck, MD, University Hospital Würzburg, Würzburg, Germany
• Date and time: Wednesday, February 7, 3:00 – 5:00 p.m. PT
• Location: Exhibit Hall, Kiosk 41-F
  

Abstract Title: Prevalence of migalastat-amenable mutations in patients with Fabry disease from Brazil, Argentina and Colombia (Poster #262)

• Presenter: Juan Politei, MD, Foundation for the Study of Neurometabolic Diseases, Buenos Aires, Argentina
• Date and time: Wednesday, February 7, 3:00 – 5:00 p.m. PT
• Location: Exhibit Hall, Kiosk 44-F
  

Abstract Title: Treatment-related benefit and satisfaction in patients with Fabry disease: Insight into patients’ expectations and preferences from the SATIS-Fab study (Poster #189)

• Presenter: Didier Lacombe, MD, Bordeaux Hospital University Center, Bordeaux, France
• Date and time: Wednesday, February 7, 3:00 – 5:00 p.m. PT
• Location: Exhibit Hall, Kiosk 34-B
  

Abstract Title: FollowME Fabry Pathfinders registry: Renal effectiveness in a cohort of patients on migalastat treatment for at least three years (Poster #339)

• Presenter: Michael West, MD, Dalhousie University, Halifax, Canada
• Date and time: Wednesday, February 7, 3:00 – 5:00 p.m. PT
• Location: Exhibit Hall, Kiosk 49-D
  

Abstract Title: Exploring the experience of females living with Fabry disease in North America (Poster #8)

• Presenter: Julia Alton, Executive Director, Canadian Fabry Association, Ontario, Canada
• Date and time: Wednesday, February 7, 3:00 – 5:00 p.m. PT
• Location: Exhibit Hall, Kiosk 2-F